Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases.

IF 6.2 Q1 IMMUNOLOGY
ImmunoTargets and Therapy Pub Date : 2024-06-10 eCollection Date: 2024-01-01 DOI:10.2147/ITT.S456326
Sha-Sha Tao, Fan Cao, Ruo-Di Zhang, Shu-Zhen Xu, Xiao-Xiao Li, Jian Tang, Xiao-Ke Yang, Hai-Feng Pan
{"title":"Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases.","authors":"Sha-Sha Tao, Fan Cao, Ruo-Di Zhang, Shu-Zhen Xu, Xiao-Xiao Li, Jian Tang, Xiao-Ke Yang, Hai-Feng Pan","doi":"10.2147/ITT.S456326","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cytokines act a vital role in autoimmune neuroinflammatory diseases (ANDs) with undetermined causal relationships. Mendelian randomization (MR) analysis was performed to estimate the causal effects of circulating levels of cytokines on the risk of ANDs.</p><p><strong>Methods: </strong>The causal relationship between 34 circulating cytokines and 4 kinds of ANDs, including multiple sclerosis (MS), neuromyelitis optica (NOM), chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) were explored using four methods of MR analysis. MR-PRESSO, MR-Egger regression methods and Cochran's Q statistic were utilized to identify the instrumental variables (IVs) with potential pleiotropy and heterogeneity. The Bonferroni correction was used for multiple group comparisons. <i>P</i>-value less than 3.68E-04 (0.05/ (34*4)) was considered statistically significant.</p><p><strong>Results: </strong>Negative causal effects of circulating levels of interleukin (IL)-8 (OR = 0.648, 95% CI: 0.494-0.851, <i>P</i> = 0.002) on risk of MS, chemokine (C-C Motif) ligand (CCL)-5 (OR = 0.295, 95% CI: 0.103-0.841, <i>P</i> = 0.022) and stem cell growth factor-beta (SCGF-β) (OR = 0.745, 95% CI: 0.565-0.984, <i>P</i> = 0.038) on risk of CIDP, as well as positive causal effects of circulating levels of IL-2 receptor α (IL-2Rα) (OR = 1.216, 95% CI: 1.120-1.320, <i>P</i> = 3.20E-06) and chemokine C-X-C motif ligand (CXCL)-10 (OR = 1.404, 95% CI: 1.094-1.803, <i>P</i> = 0.008) on MS were observed. Nevertheless, only IL-2Rα still had a causal effect on MS after Bonferroni correction.</p><p><strong>Conclusion: </strong>The results identify a genetically predicted causal effect of IL-2Rα, IL-8 and CXCL-10 on MS, CCL-5 and SCGF-β on CIDP.</p>","PeriodicalId":30986,"journal":{"name":"ImmunoTargets and Therapy","volume":"13 ","pages":"273-286"},"PeriodicalIF":6.2000,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11178096/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ImmunoTargets and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/ITT.S456326","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cytokines act a vital role in autoimmune neuroinflammatory diseases (ANDs) with undetermined causal relationships. Mendelian randomization (MR) analysis was performed to estimate the causal effects of circulating levels of cytokines on the risk of ANDs.

Methods: The causal relationship between 34 circulating cytokines and 4 kinds of ANDs, including multiple sclerosis (MS), neuromyelitis optica (NOM), chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) were explored using four methods of MR analysis. MR-PRESSO, MR-Egger regression methods and Cochran's Q statistic were utilized to identify the instrumental variables (IVs) with potential pleiotropy and heterogeneity. The Bonferroni correction was used for multiple group comparisons. P-value less than 3.68E-04 (0.05/ (34*4)) was considered statistically significant.

Results: Negative causal effects of circulating levels of interleukin (IL)-8 (OR = 0.648, 95% CI: 0.494-0.851, P = 0.002) on risk of MS, chemokine (C-C Motif) ligand (CCL)-5 (OR = 0.295, 95% CI: 0.103-0.841, P = 0.022) and stem cell growth factor-beta (SCGF-β) (OR = 0.745, 95% CI: 0.565-0.984, P = 0.038) on risk of CIDP, as well as positive causal effects of circulating levels of IL-2 receptor α (IL-2Rα) (OR = 1.216, 95% CI: 1.120-1.320, P = 3.20E-06) and chemokine C-X-C motif ligand (CXCL)-10 (OR = 1.404, 95% CI: 1.094-1.803, P = 0.008) on MS were observed. Nevertheless, only IL-2Rα still had a causal effect on MS after Bonferroni correction.

Conclusion: The results identify a genetically predicted causal effect of IL-2Rα, IL-8 and CXCL-10 on MS, CCL-5 and SCGF-β on CIDP.

循环细胞因子与自身免疫性神经炎疾病风险的孟德尔随机分析
背景:细胞因子在自身免疫性神经炎性疾病(ANDs)中发挥着重要作用,但其因果关系尚不确定。为了估算循环细胞因子水平对自身免疫性神经炎症疾病风险的因果关系,我们进行了孟德尔随机分析(MR):方法:采用四种 MR 分析方法探讨了 34 种循环细胞因子与多发性硬化症(MS)、神经性脊髓炎(NOM)、慢性炎症性脱髓鞘性多发性神经病(CIDP)和重症肌无力(MG)等 4 种 ANDs 之间的因果关系。利用 MR-PRESSO、MR-Egger 回归方法和 Cochran's Q 统计量来识别具有潜在多向性和异质性的工具变量(IV)。多组比较采用 Bonferroni 校正。P值小于 3.68E-04 (0.05/ (34*4)) 被认为具有统计学意义:白细胞介素(IL)-8(OR = 0.648,95% CI:0.494-0.851,P = 0.002)、趋化因子(C-C Motif)配体(CCL)-5(OR = 0.295,95% CI:0.103-0.841,P = 0.022)和干细胞生长因子-β(SCGF-β)循环水平对多发性硬化症风险的负因果效应(OR = 0.745,95% CI:0.此外,还观察到IL-2受体α(IL-2Rα)(OR = 1.216,95% CI:1.120-1.320,P = 3.20E-06)和趋化因子C-X-C mot配体(CXCL)-10(OR = 1.404,95% CI:1.094-1.803,P = 0.008)的循环水平对多发性硬化症的正向因果效应。尽管如此,经 Bonferroni 校正后,只有 IL-2Rα 仍对多发性硬化症有因果效应:结论:研究结果表明,IL-2Rα、IL-8 和 CXCL-10 对多发性硬化症、CCL-5 和 SCGF-β 对 CIDP 有遗传预测的因果效应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
16.50
自引率
0.00%
发文量
7
审稿时长
16 weeks
期刊介绍: Immuno Targets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered.In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信